ANX Mast Therapeutics, Inc.

SAN DIEGO, Nov. 14 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (AMEX:ANX) announced today that Evan M. Levine, chief executive officer, will deliver a corporate presentation at the BIOCOM San Diego Investor Conference on Wednesday, November 15, 2006 at 3:20 p.m. Pacific Time (6:20 pm Eastern Time). A link to the live audio webcast will be available via the "Investors" section of the Company's Web site at http://www.adventrx.com/ under "Events". The replay of the corporate presentation will be available for 14 days following the event. The BIOCOM San Diego Investor Conference will take place on November 14-16, 2006 at the San Diego Marriott in Del Mar, CA. About ADVENTRX ADVENTRX Pharmaceuticals is a biopharmaceutical research and development company focused on introducing treatments for cancer and infectious disease that surpass the performance and safety of existing drugs, by addressing significant problems such as drug metabolism, toxicity, bioavailability and resistance. More information can be found on the Company's Web site at http://www.adventrx.com/. Forward Looking Statement This press release contains forward-looking statements, within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, regarding ADVENTRX. Such statements are made based on management's current expectations and beliefs. Actual results may vary from those currently anticipated based upon a number of factors, including uncertainties inherent in the drug development process, the timing and success of clinical trials, the validity of research results, and the receipt of necessary approvals from the FDA and other regulatory agencies. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements regarding ADVENTRX, see the section titled "Risk Factors" in ADVENTRX's last annual report on Form 10-K and its Quarterly Reports on Form 10-Q, as well as other reports that ADVENTRX files from time to time with the Securities and Exchange Commission. All forward-looking statements regarding ADVENTRX are qualified in their entirety by this cautionary statement. ADVENTRX undertakes no obligation to release publicly any revisions to forward-looking statements to reflect events or circumstances which occur after the date hereof. DATASOURCE: ADVENTRX Pharmaceuticals, Inc. CONTACT: Ioana Hone for ADVENTRX Pharmaceuticals, +1-858-552-0866 Web site: http://www.adventrx.com/

Copyright